Gilead Sciences (GILD) FCF Margin (2009 - 2026)

Gilead Sciences has reported FCF Margin for 18 years, with the latest figure at 34.87% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 1008.0% year-over-year to 34.87%; the trailing twelve-month figure through Mar 2026 stood at 34.4% (up 14.0% YoY), and the FY2025 full-year result was 32.12%, down 372.0% from the prior year.
• FCF Margin for Q1 2026 stood at 34.87%, down from 39.39% in the prior quarter.
• The five-year high for FCF Margin was 55.24% in Q3 2024, with the low at 10.17% in Q2 2025.
• Historically, FCF Margin has averaged 31.34% across 5 years, with a median of 31.62% in 2024.
• The largest YoY upside for FCF Margin was 3208 bps in 2024 against a maximum downside of 1614 bps in 2024.
• Gilead Sciences' FCF Margin stood at 32.29% in 2022, then dropped by 15 bps to 27.47% in 2023, then surged by 36 bps to 37.36% in 2024, then advanced by 5 bps to 39.39% in 2025, then decreased by 11 bps to 34.87% in 2026.
• The last three FCF Margin figures came in at 34.87% (Q1 2026), 39.39% (Q4 2025), and 50.98% (Q3 2025), per Business Quant data.